Chaoying Yang

Hunan Province Key Laboratory Of Basic And Applied Hematology
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Calpain-2 inhibition alleviates hypercalcemia-driven multiple myeloma progression.

Calpain-2 inhibition alleviates hypercalcemia-driven multiple myeloma progression.

Journal: Biochemical pharmacology

Published: March 13, 2026

Corrigendum to "STAT1-VAMP8 axis drives nasopharyngeal carcinoma progression via autophagy enhancement" [Biochem. Pharmacol. 242(Part 3) (2025) 117299].

Corrigendum to "STAT1-VAMP8 axis drives nasopharyngeal carcinoma progression via autophagy enhancement" [Biochem. Pharmacol. 242(Part 3) (2025) 117299].

Journal: Biochemical pharmacology

Published: October 11, 2025

The role of m6A reader IGF2BPs in tumor metabolic reprogramming.

The role of m6A reader IGF2BPs in tumor metabolic reprogramming.

Journal: Biochemical pharmacology

Published: September 03, 2025

Celastrol induces apoptosis of myelodysplastic syndrome cells through a ROS-dependent pro-apoptotic endoplasmic-reticulum stress pathway.

Celastrol induces apoptosis of myelodysplastic syndrome cells through a ROS-dependent pro-apoptotic endoplasmic-reticulum stress pathway.

Journal: Cancer cell international

Published: June 30, 2025

STAT1-VAMP8 axis drives nasopharyngeal carcinoma progression via autophagy enhancement.

STAT1-VAMP8 axis drives nasopharyngeal carcinoma progression via autophagy enhancement.

Journal: Biochemical pharmacology

Published: February 27, 2025

Lysine succinylation precisely controls normal erythropoiesis.

Lysine succinylation precisely controls normal erythropoiesis.

Journal: Haematologica

Published: April 24, 2024

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets.

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets.

Journal: Cell death & disease

Published: April 15, 2024

RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway.

RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway.

Journal: Cell death & disease

Published: March 05, 2024

The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression.

The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression.

Journal: Cancer research

Published: December 18, 2023

Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma.

Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma.

Journal: Cancers

Published: January 15, 2023

The role of m6A-mediated PD-1/PD-L1 in antitumor immunity.

The role of m6A-mediated PD-1/PD-L1 in antitumor immunity.

Journal: Biochemical pharmacology

Published: December 18, 2022

Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma.

Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma.

Journal: Cancer letters

Published: May 11, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026